AngioDynamics, Inc. (ANGO)

15.88 +0.11 (+0.70%) USD  |  NASDAQ  |  Aug 25, 14:23
More

AngioDynamics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for ANGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
July 15, 2026 --
July 14, 2026 --
April 06, 2026 --
April 02, 2026 --
January 07, 2026 --
January 06, 2026 --
December 17, 2025 --
October 27, 2025 --
October 06, 2025 --
October 03, 2025 --
October 02, 2025 --
September 12, 2025 --
July 25, 2025 --
Date Value
July 16, 2025 --
April 07, 2025 --
April 03, 2025 --
January 10, 2025 --
January 09, 2025 --
December 10, 2024 --
October 04, 2024 --
July 17, 2024 --
July 16, 2024 --
July 12, 2024 --
May 22, 2024 --
April 05, 2024 --
April 04, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Penumbra, Inc. Upgrade
Abbott Laboratories Upgrade
Alphatec Holdings, Inc. Upgrade
AtriCure, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade